Manufacturer · Saudi Arabia
Cangene BioPharma Inc. (CBI)
5 medicines in 1 country, as manufacturer.
Loading your page…
Loading your page…
Manufacturer · Saudi Arabia
5 medicines in 1 country, as manufacturer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
5 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ELAPRASE 2 mg/ml concentrate for solution for infusion | Idursulfase | Saudi Arabia | Authorised | |
| Empaveli 1080 mg per 20 ml | Pegcetacoplan | Saudi Arabia | Authorised | |
| Empaveli 1080 mg per 20 ml 8 vials | Pegcetacoplan | Saudi Arabia | Authorised | |
| REPLAGAL 1mg/ml concetrate for solution for infusion | Agalsidase alfa | Saudi Arabia | Authorised | |
| VPRIV 40 U POWDER FOR SOLUTION FOR INFUSION | Velaglucerase alfa | Saudi Arabia | Authorised |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Saudi Arabia | 5 | 5 | 0 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Report an error or request removalCorrections from the company itself are welcome.
Ranked by their number of medicines.